Literature DB >> 16180253

The ratio between dendritic cells and T cells determines the outcome of their encounter: proliferation versus deletion.

Uta E Höpken1, Insa Lehmann, Jana Droese, Martin Lipp, Thomas Schüler, Armin Rehm.   

Abstract

Dendritic cells (DC) either induce T cell tolerance or contribute to the initiation and modulation of T and B cell responses. Since many of the variables determining the thresholds of naive T cell priming were defined in vitro using a homogeneously matured DC population, we here focused on partially mature DC which might reflect the occurrence of tumor-infiltrating and thymic DC. To predict how those DC regulate the induction of antigen-specific T cell proliferation and T cell tolerance, we co-cultured ovalbumin-pulsed murine DC at different ratios with antigen-specific DO11.10 transgenic T cells. Whereas partially mature DC at a DC/T cell ratio of 1:10 supported proliferation, a DC/T cell ratio of 1:2 induced proliferation arrest in naive CD4+ T cells. The acquisition of the NK cell inhibitory markers NK1.1 and KLRG on T cells exposed to high numbers of DC suggests a role for these molecules in the protection of antigen-responsive T cells from exhaustion by overstimulation. Mechanistically, abortive T cell proliferation upon encounter of high numbers of partially mature DC is caused by an apoptosis-related pathway, suggesting that excessive antigen density without sufficient costimulation results in activation-induced cell death.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16180253     DOI: 10.1002/eji.200526298

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  18 in total

1.  Tolerogenic effect of mouse fibroblasts on dendritic cells.

Authors:  Mohsen Khosravi-Maharlooei; MohammadReza Pakyari; Reza B Jalili; Sanam Salimi-Elizei; Jacqueline C Y Lai; Malihesadat Poormasjedi-Meibod; Ruhangiz T Kilani; Jan Dutz; Aziz Ghahary
Journal:  Immunology       Date:  2016-02-08       Impact factor: 7.397

2.  A novel dendritic cell-based direct ex vivo assay for detection and enumeration of circulating antigen-specific human T cells.

Authors:  Roberto Carrio; Ge Zhang; Donald R Drake; Brian C Schanen
Journal:  Cytotechnology       Date:  2018-05-07       Impact factor: 2.058

3.  CD28 ligation increases macrophage suppression of T-cell proliferation.

Authors:  Daniel Silberman; Amanda Bucknum; Thomas Bartlett; Gabriella Composto; Megan Kozlowski; Amanda Walker; Amy Werda; Jackelyn Cua; Arlene H Sharpe; John E Somerville; James E Riggs
Journal:  Cell Mol Immunol       Date:  2012-04-23       Impact factor: 11.530

4.  Immune-regulating strategy against rheumatoid arthritis by inducing tolerogenic dendritic cells with modified zinc peroxide nanoparticles.

Authors:  Han Qiao; Jingtian Mei; Kai Yuan; Kai Zhang; Feng Zhou; Tingting Tang; Jie Zhao
Journal:  J Nanobiotechnology       Date:  2022-07-14       Impact factor: 9.429

5.  The tumor-associated antigen EBAG9 negatively regulates the cytolytic capacity of mouse CD8+ T cells.

Authors:  Constantin Rüder; Uta E Höpken; Jana Wolf; Hans-Willi Mittrücker; Boris Engels; Bettina Erdmann; Susanne Wollenzin; Wolfgang Uckert; Bernd Dörken; Armin Rehm
Journal:  J Clin Invest       Date:  2009-07-20       Impact factor: 14.808

6.  New insights into the role of the aryl hydrocarbon receptor in the function of CD11c⁺ cells during respiratory viral infection.

Authors:  Guang-Bi Jin; Bethany Winans; Kyle C Martin; B Paige Lawrence
Journal:  Eur J Immunol       Date:  2014-03-19       Impact factor: 5.532

7.  The transcription factor C/EBPβ orchestrates dendritic cell maturation and functionality under homeostatic and malignant conditions.

Authors:  Florian Scholz; Michael Grau; Lutz Menzel; Annika Graband; Myroslav Zapukhlyak; Achim Leutz; Martin Janz; Georg Lenz; Armin Rehm; Uta E Höpken
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-05       Impact factor: 11.205

8.  Cytokine treatment of macrophage suppression of T cell activation.

Authors:  Daniel Silberman; Amanda Bucknum; Megan Kozlowski; Robin Matlack; James Riggs
Journal:  Immunobiology       Date:  2009-02-26       Impact factor: 3.144

9.  Noncognate Signals Drive Enhanced Effector CD8+ T Cell Responses through an IFNAR1-Dependent Pathway after Infection with the Prototypic Vaccine, 0ΔNLS, against Herpes Simplex Virus 1.

Authors:  Grzegorz B Gmyrek; Paul Predki; Edward Gershburg; Daniel J J Carr
Journal:  J Virol       Date:  2022-01-19       Impact factor: 6.549

10.  A facile approach to enhance antigen response for personalized cancer vaccination.

Authors:  Aileen Weiwei Li; Miguel C Sobral; Soumya Badrinath; Youngjin Choi; Amanda Graveline; Alexander G Stafford; James C Weaver; Maxence O Dellacherie; Ting-Yu Shih; Omar A Ali; Jaeyun Kim; Kai W Wucherpfennig; David J Mooney
Journal:  Nat Mater       Date:  2018-03-05       Impact factor: 43.841

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.